ACADIA PHARMACEUTICALS INC Annual Costs and Expenses in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Acadia Pharmaceuticals Inc quarterly/annual Costs and Expenses history and growth rate from 2014 to 2023.
  • Acadia Pharmaceuticals Inc Costs and Expenses for the quarter ending September 30, 2024 was $219M, a 18.8% decline year-over-year.
  • Acadia Pharmaceuticals Inc Costs and Expenses for the twelve months ending September 30, 2024 was $817M, a 3.91% increase year-over-year.
  • Acadia Pharmaceuticals Inc annual Costs and Expenses for 2023 was $800M, a 7.96% increase from 2022.
  • Acadia Pharmaceuticals Inc annual Costs and Expenses for 2022 was $741M, a 13.2% increase from 2021.
  • Acadia Pharmaceuticals Inc annual Costs and Expenses for 2021 was $655M, a 10.1% decline from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $800M +$59M +7.96% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $741M +$86.2M +13.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $655M -$73.8M -10.1% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $728M +$143M +24.4% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $586M +$114M +24.3% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $471M +$53.9M +12.9% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $417M +$127M +43.8% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 $290M +$125M +76.2% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
2015 $165M +$71.3M +76.4% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-27
2014 $93.4M Jan 1, 2014 Dec 31, 2014 10-K 2017-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.